Comments
Analysis: Failed Alzheimer's drug may get second chance
09.08.2012. | CHICAGO (Reuters) - Pfizer and Johnson & Johnson's Alzheimer's drug failed to help patients showing early signs of the disease, but it could get another chance as scientists test whether the devastating illness should be treated before symptoms appear....
